Previously, high UCHL5 expression has been linked to poor prognosis or cancer recurrence in esophageal squamous cell carcinoma, epithelial ovarian cancer, and in hepatocellular carcinoma [16–18]. This evidence concerns the gene UCHL5 and hepatocellular carcinoma.